Partner

At a glance

6

Finished Products

6

Therapy Areas

1+

Delivery Formats

C3-CURA™

Primary Platform

All products
Corn SilkIngredient · 09/14

Corn Silk

Glycosylated flavone – Corn Silk

Market Landscape

The opportunity – and where the market falls short.

  • 01Natural diuretic – urine flow, fluid balance, urinary health
  • 02Targeted benefits – UTIs, kidney support, inflammation, metabolic
  • 03Traditional relevance with modern use
  • 04Emerging opportunity in urology and metabolic health
  • 05Niche market with limited capsule/tea formats
The Stabicon Edge

From market limitation to measurable transformation.

Market LimitationStabicon TransformationImpact
Low AwarenessTargeted Health PositioningRecognition as a functional urology ingredient
Limited Clinical PositioningCondition-Led Approach – UTI, fluid retention, kidney, weightStronger relevance
Traditional Formats OnlyMulti-Format Delivery – sachets, liquids, tablets, blendsWider consumer reach
Lack of StandardizationStandardized ExtractsConsistent efficacy and quality
No Format InnovationModern Delivery SystemsBetter differentiation
Untapped Preventive SegmentDaily Urinary Health PlatformRepeat-use preventive portfolio
Stabicon's Portfolio

Corn Silk reimagined across therapy areas and delivery formats.

Every finished product powered by Corn Silk. Filter by therapy area, and tap any ingredient to open its market landscape and Stabicon edge.

Filter
0 products

No products match those filters.

Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Unsubscribe in one click. Your email stays with us.

Press Kit

Logos, fact sheet & spokesperson bios – all in one download.

Download Press Kit (ZIP)

For media queries: press@stabicon.com

Accreditations

ISO/IEC 17025:2017 (NABL)WHO Geneva – Audited & ApprovedFSSAI ApprovedCDSCO IndiaUS FDA – Registered FacilityDSIR RegisteredAYUSH Registered

Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Product packaging and materials may vary from those shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.

Admin